fraction
aqueou
extract
tender
leaf
toona
sinensi
roem
nutriti
veget
pandem
influenza
viru
recent
describ
rapidli
contagi
respiratori
pathogen
caus
acut
respiratori
distress
syndrom
ard
pose
major
public
health
threat
studi
found
inhibit
viral
yield
mdck
plaqu
format
pandem
influenza
viru
infect
cell
high
select
index
meanwhil
also
suppress
viral
genom
load
infect
cell
quantifi
qrtpcr
studi
demonstr
inhibit
pandem
influenza
viru
activ
prevent
attach
cell
penetr
inhibit
viral
attach
signific
downregul
adhes
molecul
chemokin
eselectin
fractalkin
compar
amantadin
result
suggest
may
use
altern
treatment
prophylaxi
pandem
influenza
viru
pandem
influenza
viru
new
strain
viru
identifi
mexico
april
spread
rapidli
across
globe
accord
statist
pandem
viru
kill
peopl
around
world
sinc
past
year
worldwid
effort
viru
isol
whole
genom
sequenc
hemagglutin
inhibit
assay
confirm
influenza
virus
led
deposit
sequenc
influenza
viru
resourc
nation
center
biotechnolog
inform
ncbi
genom
analysi
influenza
viru
human
indic
close
relat
common
reassort
swine
influenza
virus
isol
north
america
europ
asia
pandem
influenza
viru
compris
rna
segment
north
american
eurasian
swine
influenza
avian
influenza
virus
morlighem
et
al
found
pandem
influenza
viru
high
evolutionari
rate
soon
thereaft
oseltamivirresist
pandem
influenza
viru
found
therefor
prudent
find
new
antivir
agent
tender
leav
toona
sinensi
ts
tradit
regard
nutrit
supplement
veget
mainland
china
taiwan
recent
report
evidencebas
complementari
altern
medicin
signific
toxic
effect
biochem
histopatholog
paramet
femal
mice
treat
extract
ts
extract
ts
leav
wide
rang
biolog
function
includ
glycem
control
antildl
glyc
activ
improv
cognit
function
ts
extract
also
demonstr
inhibit
cancer
cell
growth
human
ovarian
cancer
human
premyelocyt
leukemia
human
lung
adenocarcinoma
prostat
cancer
mechan
anticanc
activ
ts
could
due
gener
reactiv
oxygen
speci
mitochondriamedi
apoptosi
moreov
ts
possess
antiangiogen
activ
suppress
vegfinduc
express
metalloproteinas
mmp
endotheli
cell
tradit
chines
medicin
tcm
may
great
treasur
find
new
antivir
agent
influenza
viru
wang
et
al
found
maxingshiganyinqiaosan
may
use
altern
treatment
influenza
viru
infect
hsieh
et
al
report
maxingshigan
tang
abolish
entri
influenza
viru
regul
kakt
pathway
aqueou
extract
dandelion
possess
inhibit
replic
mdck
cell
although
mani
tcm
herb
found
antiinfluenza
properti
mechan
yet
clearli
verifi
previou
studi
found
major
fraction
tender
leav
ts
known
signific
inhibitori
effect
coronaviru
famili
viru
includ
sar
coronaviru
induc
sever
acut
respiratori
syndrom
sar
global
outbreak
addit
tender
leav
ts
appear
benefici
prevent
upper
respiratori
infect
clinic
experi
know
adhes
molecul
upregul
alveolar
epitheli
cell
respons
tnfstimul
bacteri
viral
infect
first
discov
extract
toona
sinensi
antiinfluenza
effect
modul
adhes
molecul
chemokin
herein
analyz
whether
antiinfluenza
activ
cell
cultur
attempt
delin
relev
mechan
studi
conclud
may
inhibit
influenza
viru
infect
potenti
promis
treatment
protect
host
pandem
influenza
viru
fraction
crude
extract
tender
leaf
toona
sinensi
roem
prepar
accord
previou
studi
brief
g
tender
leav
yield
approxim
g
lyophil
powder
aqueou
extract
ts
character
highperform
liquid
chromatographi
hplc
nine
compound
gallic
acid
methyl
gallat
ethyl
gallat
kaempferol
kaempferol
dglucosid
quercetin
quercitrin
quercetin
dglucosid
rutin
identifi
ts
previous
describ
antivir
assay
pandem
influenza
viru
dissolv
water
dilut
cell
cultur
medium
cytotox
effect
grow
mdck
cell
determin
xtt
tetrazolium
hydroxid
salt
assay
accord
manufactur
instruct
roch
molecular
diagnost
germani
briefli
cell
cellswel
plate
cultur
plate
incub
period
hour
variou
concentr
gml
supplement
immedi
incub
c
co
day
xtt
reagent
ad
incub
hour
absorb
result
solut
measur
spectrophotometr
nm
sunris
tecan
refer
nm
experi
carri
triplic
perform
least
thrice
separ
cytotox
concentr
cc
calcul
select
index
calcul
ratio
cc
ec
monolay
cell
concentr
cellsml
infect
pandem
influenza
viru
pfuml
hour
solut
remov
cell
wash
twice
phosphat
buffer
salin
pb
supplement
growth
media
contain
differ
concentr
amantadin
use
posit
control
cell
harvest
hour
afterinfect
viral
yield
estim
quantit
rtpcr
plaqu
assay
mdck
cell
vehicl
control
infect
cell
incub
medium
includ
throughout
experi
assay
confluent
monolay
cell
plate
infect
pandem
influenza
viru
pfuml
hour
replac
medium
contain
variou
concentr
virus
harvest
hour
infect
use
process
three
cycl
freez
thaw
clarifi
low
speed
centrifug
g
min
viru
yield
cultur
supernat
assay
plaqu
assay
mdck
cell
briefli
confluent
monolay
mdck
cell
cultur
tissu
cultur
plate
cellscm
infect
supernat
minut
viru
adsorpt
solut
remov
cell
wash
twice
prewarm
mem
medium
replac
overlay
medium
mem
contain
gml
trypsin
low
melt
agaros
without
serum
contain
amantadin
differ
concentr
incub
cultur
hour
c
co
monolay
fix
formaldehyd
solut
minut
agaros
remov
flow
water
stain
wv
crystal
violet
solut
assay
perform
plate
triplic
plaqu
count
quantiti
one
version
biorad
laboratori
examin
percentag
plaqu
inhibit
calcul
rel
vehicl
control
requir
concentr
reduc
plaqu
number
ec
calcul
regress
analysi
doserespons
curv
gener
data
total
nucleic
acid
extract
magnapur
instrument
roch
molecular
diagnost
germani
use
manufactur
extern
lysi
protocol
extract
reagent
total
nucleic
acid
isol
kit
roch
molecular
diagnost
germani
yield
l
eluat
pcr
assay
perform
use
standard
precaut
avoid
contamin
primer
sens
acc
aat
cct
gtc
acctct
antisens
agc
gtc
tac
gctgca
gtc
amplifi
pair
fragment
gene
influenza
influenza
specif
probe
fam
gtg
ttc
acg
ctc
acc
quantit
assay
l
rtpcr
mixtur
contain
univers
pcr
master
mix
multiscrib
rnase
inhibitor
nm
forward
revers
primer
nm
taqman
probe
l
extract
rna
water
templat
control
reaction
perform
analyz
sequenc
detect
system
prism
appli
biosystem
usa
follow
condit
minut
c
minut
c
follow
cycl
second
c
minut
c
plasmid
contain
known
copi
number
amplif
target
includ
realtim
pcr
assay
gener
standard
curv
quantif
test
sampl
assay
cell
seed
incub
hour
prechil
c
hour
medium
aspir
cell
infect
pandem
influenza
viru
pfuml
differ
indic
concentr
incub
c
anoth
hour
medium
aspir
remov
unabsorb
viru
cell
wash
pb
three
time
incub
addit
hour
assay
quantit
rtpcr
qrtpcr
describ
assay
cell
grown
cultur
plate
prechil
c
hour
cell
infect
pandem
influenza
viru
pfuml
incub
c
anoth
hour
allow
viral
attach
cell
surfac
differ
concentr
supplement
cell
incub
c
co
hour
maxim
penetr
virus
infect
cell
treat
pb
ph
minut
inactiv
unpenetr
virus
pb
ph
supplement
immedi
neutral
alkalin
pb
ph
neutral
pb
remov
cell
supplement
fresh
cultur
medium
incub
c
addit
hour
cell
assay
qrtpcr
describ
follow
treatment
procedur
attach
assay
penetr
assay
cell
cultur
supernat
collect
one
hundr
microlit
supernat
fresh
prepar
guinea
pig
erythrocyt
suspens
ad
ushap
microtitr
plate
mix
thoroughli
plate
incub
hour
c
rbc
agglutin
observ
experi
repeat
three
time
independ
follow
treatment
procedur
attach
assay
penetr
assay
cell
probe
neuraminidas
antibodi
abcam
cambridg
usa
c
hour
wash
three
time
pb
cell
incub
horseradish
peroxidas
conjug
secondari
antibodi
millipor
bedford
usa
hour
room
temperatur
tmb
solut
cell
signal
boston
usa
ad
incub
minut
ad
stop
solut
cell
signal
absorb
result
solut
measur
spectrophotometr
nm
sunris
tecan
experi
repeat
three
time
independ
follow
treatment
procedur
attach
assay
penetr
assay
cell
cultur
supernat
collect
human
sialic
acidspecif
sigma
use
determin
level
sialic
acid
condit
media
collect
cell
experiment
step
carri
describ
protocol
provid
manufactur
perform
three
time
time
analyz
duplic
respect
monolay
cell
concentr
cellsml
infect
pandem
influenza
viru
pfuml
hour
solut
remov
cell
wash
twice
phosphat
buffer
salin
pb
supplement
growth
media
contain
differ
concentr
cell
supernat
collect
hour
describ
protocol
provid
manufactur
r
system
inc
minneapoli
mn
usa
perform
three
time
time
analyz
duplic
respect
chain
reaction
qrtpcr
analysi
total
cellular
rna
isol
lysi
cell
guanidinium
isothiocyan
buffer
follow
singl
step
phenolchloroformisoamyl
alcohol
extract
procedur
modifi
previous
describ
briefli
untreat
treat
cell
membran
expos
fuji
medic
xray
film
fuji
ltd
tokyo
japan
minut
statist
analys
perform
use
sigmastat
statist
softwar
version
jandel
scientif
ca
usa
result
repres
mean
standard
deviat
sd
anova
carri
multipl
comparison
evalu
valu
consid
signific
less
experi
repeat
least
three
time
independ
estim
extract
higher
gml
figur
cell
determin
effect
viral
growth
infect
cell
first
character
viral
plaqu
morpholog
mdck
cell
shown
figur
chang
viral
yield
plaqu
format
demonstr
inhibitori
effect
dosedepend
manner
inhibitori
effect
viral
yield
plaqu
format
demonstr
without
dosedepend
manner
concentr
gml
display
similar
inhibitori
effect
viral
yield
plaqu
format
therefor
gml
amantadin
whole
research
program
use
posit
control
figur
found
concentr
gml
decreas
approxim
plaqu
format
viral
yield
virtual
complet
inhibit
viral
yield
observ
highest
concentr
gml
treatment
figur
b
mean
inhibitori
concentr
ec
gml
viru
select
index
si
calcul
ratio
cc
ec
si
least
indic
strong
inhibitori
effect
pandem
influenza
viru
without
cytotox
effect
mdck
cell
cell
qrtpcr
effect
viral
genom
load
infect
shown
copi
number
decrement
treatment
calcul
absolut
quantif
cell
infect
pandem
influenza
viru
incub
hour
presenc
variou
concentr
total
rna
isol
infect
cell
qrtpcr
analysi
perform
use
specif
primer
viral
gene
rna
qrtpcr
result
demonstr
signific
inhibit
viral
rna
synthesi
infect
cell
concentr
greater
gml
treatment
figur
howev
signific
chang
viral
genom
load
infect
cell
gml
treatment
amantadin
accord
result
plaqu
assay
viral
genom
load
demonstr
antiinfluenza
viru
activ
hypothes
might
inhibit
viral
attach
andor
penetr
viral
entranc
cell
shown
figur
viral
genom
load
detect
qrtpcr
could
significantli
inhibit
viral
attach
prevent
entranc
host
cell
treatment
less
gml
contrari
could
exert
effect
inhibit
viral
penetr
cell
even
gml
treatment
figur
b
examin
whether
inhibitori
activ
toward
na
attach
penetr
process
result
demonstr
possess
inhibitori
activ
na
attach
effect
dosedepend
manner
figur
c
penetr
effect
figur
influenza
viru
abil
adsorb
guinea
pig
red
blood
cell
result
ha
investig
could
interfer
viral
adsorpt
rbc
result
ha
inhibit
minimum
concentr
gml
treatment
procedur
attach
assay
inhibit
adsorpt
abil
viru
figur
e
gml
treatment
procedur
penetr
assay
result
inhibit
adsorpt
viru
figur
f
conclud
result
inhibit
pandem
influenza
viru
activ
inhibit
attach
cell
viral
penetr
viru
receptor
hemagglutinin
ha
influenza
viru
sialic
acid
sa
initi
attach
import
stage
viru
infect
cell
therefor
test
whether
figur
b
sialic
acid
significantli
suppress
treatment
viral
attach
assay
viral
penetr
assay
evid
attach
assay
sialic
acid
also
suppress
treatment
amantadin
howev
effect
weaker
rant
produc
virusinfect
alveolar
epitheli
cell
implic
variou
pathophysiolog
process
includ
inflamm
furthermor
rant
express
suppress
amantadin
treatment
viral
infect
cell
shown
figur
c
howev
statist
signific
amantadin
process
inflammatori
effect
immun
activ
host
cell
protect
toward
respiratori
endotheli
cell
respons
influenza
viru
infect
associ
releas
proinflammatori
cytokin
adhes
molecul
along
varieti
chemokin
found
mrna
eselectin
fractalkin
activ
viral
infect
suppress
treatment
figur
amantadin
report
appropri
empir
treatment
influenza
associ
infect
lower
respiratori
tract
pneumonia
amantadin
inhibitori
effect
gene
express
cell
presenc
absenc
viral
infect
compar
figur
b
mrna
level
eselectin
fractalkin
inhibit
amantadin
effici
suppress
gene
express
molecul
comparison
amantadin
figur
b
demonstr
amantadin
effect
inhibit
mrna
express
without
vial
activ
howev
effici
reduc
mrna
level
vial
activ
compar
amantadin
figur
b
indic
could
differ
mechan
pathway
prevent
viral
infect
amantadin
base
mrna
chang
inhibit
amantadin
explor
mechan
respons
inhibit
adhes
molecul
chemokin
express
figur
effect
amantadin
inhibit
adhes
molecul
chemokin
cell
viral
activ
figur
similar
mrna
express
found
amantadin
inhibit
express
presenc
viral
infect
compar
howev
specif
inhibitori
effect
express
absenc
viral
infect
amantadin
outbreak
pandem
influenza
viru
pose
major
public
health
risk
infect
influenza
virus
still
major
health
issu
treatment
option
limit
natur
product
deriv
histor
import
sourc
therapeut
agent
crude
extract
toona
sinensi
roem
leaf
report
exert
antiprolif
action
growth
inhibit
sever
cancer
cell
line
apoptosi
induct
recent
toona
sinensi
roem
leaf
extract
proven
abat
hyperglycemia
alter
adipos
glucos
transport
improv
lipolysi
differenti
adipocyt
also
report
extract
tender
leaf
toona
sinensi
roem
inhibit
sar
coronaviru
viru
known
caus
influenzalik
syndrom
therefor
research
whether
could
inhibit
pandem
influenza
viru
knowledg
first
vitro
studi
demonstr
activ
extract
tender
leaf
toona
sinensi
roem
natur
product
deriv
histor
invalu
sourc
therapeut
agent
report
varieti
polyphenol
flavonoid
saponin
glucosid
alkaloid
isol
medicin
herb
studi
extens
shown
antiinfluenza
activ
reflect
abil
block
adher
penetr
duplic
andor
matur
cours
viral
propag
epigallocatechin
gallat
egcg
ester
epigallocatechin
gallic
acid
report
inhibit
infect
influenza
b
virus
mdck
cell
vitro
deriv
gallic
acid
includ
lauryl
gallat
octyl
gallat
shown
significantli
inhibit
influenza
viru
product
polyphenol
antioxid
protect
human
cell
oxid
damag
might
play
role
prevent
influenza
viru
attack
kaempferol
flavonoid
exhibit
highest
activ
two
influenza
virus
also
found
isol
sophora
flavescen
suppress
rant
secret
alveolar
epitheli
cell
block
transcript
activ
nfb
part
interf
b
degrad
subsequ
decreas
nfb
transloc
recent
studi
found
quercetin
isoquercetin
dglucosid
significantli
reduc
replic
influenza
virus
vitro
vivo
protect
lung
deleteri
effect
oxygenderiv
free
radic
releas
influenza
viru
infect
addit
rutin
quercetin
exhibit
prooxid
effect
healthi
anim
antioxid
activ
influenzainfect
anim
detoxicosi
increas
hepat
monooxygenas
activ
includ
compound
major
constitu
specif
compound
inhibit
influenza
viru
investig
identif
requir
studi
test
viral
inhibitori
activ
viral
infect
mdck
cell
reduc
cpe
mdck
cell
also
reduc
viral
replic
dosedepend
manner
high
select
index
suggest
could
inhibit
viral
adsorpt
mdck
cell
thu
block
infect
might
effect
suppress
viral
growth
protect
cell
viral
damag
knowledg
earli
stage
influenzahost
cell
interact
includ
primari
attach
viru
subsequ
irrevers
attach
confirm
block
viral
entri
attach
assay
may
interact
viral
protein
alter
adsorpt
penetr
virion
studi
demonstr
effect
amantadin
inhibit
infect
moreov
mechan
amantadin
inhibit
differ
result
demonstr
inhibit
influenza
virusinduc
adhes
molecul
chemokin
express
promin
compar
amantadin
correl
well
decreas
mrna
level
cell
adhes
molecul
upregul
alveolar
epitheli
cell
respons
tnfstimul
bacteri
pneumonia
vitro
vivo
increas
adhes
molecul
express
lung
epitheli
cell
report
upon
respiratori
syncyti
viru
infect
recent
express
found
upregul
surfac
alveolar
endotheli
cell
upon
influenza
viru
infect
know
major
target
influenza
viru
infect
host
cell
locat
upper
lower
airway
influenza
viru
infect
epitheli
cell
endotheli
cell
gener
result
amplifi
viral
replic
enhanc
express
adhes
molecul
host
cell
attract
leukocyt
immun
current
studi
analys
cellular
adhes
molecul
express
respons
viru
infect
reveal
upregul
eselectin
subsequ
inhibit
indic
effect
decreas
adhes
molecul
express
protect
host
continu
viral
infect
process
inflammatori
leukocyt
recruit
toward
lung
respons
influenza
viru
infect
begin
releas
proinflammatori
cytokin
tnf
along
varieti
chemokin
like
rant
ifninduc
protein
infect
alveolar
macrophag
epitheli
cell
beck
et
al
discuss
import
chemokin
biolog
progress
acut
lung
injuri
recent
discov
lung
injuri
score
independ
predict
mortal
ard
predict
mortal
decreas
releas
tnfand
play
protect
role
decreas
vascular
permeabl
leukocyt
recruit
downregul
fractalkin
current
studi
fractalkin
product
infect
significantli
downregul
brief
inhibit
viral
infect
also
attenu
product
critic
chemokin
fractalkin
respons
acut
lung
injuri
therefor
might
potenti
decreas
infect
also
attenu
sever
acut
lung
injuri
infect
express
tolllik
receptor
tlr
famili
endotheli
cell
play
crucial
role
process
inflamm
pathogen
induct
activ
innat
immun
member
protein
famili
act
antiand
proapoptot
regul
involv
wide
varieti
cellular
activ
embryon
develop
inflamm
tumorigenesi
indic
antivir
mechan
modul
adhes
molecul
chemokin
express
differ
amantadin
modul
inflamm
summari
conclud
inhibit
pandem
influenza
viral
attach
reduc
cytokin
respons
acut
lung
injuri
effect
amantadin
inhibit
via
differ
pathway
influenza
viru
infect
impos
consider
social
econom
burden
upon
societi
nutriti
veget
toona
sinensi
roem
may
altern
supplement
tradit
antivir
therapi
